Transplant from HIV-positive donors to HIV-positive recipients
Part of Immune system & allergy, Infections, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial studies whether it’s safe and effective for HIV-positive people to receive organ transplants from HIV-positive donors. It focuses on matching HIV treatment before and after transplant and checking for major complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older and eligible for a transplant based on standard transplant listing rules
- You must have HIV confirmed by an FDA-approved test
- Your CD4 count must be at least 200 within 16 weeks before transplant (and at least 200 even if you had certain past infections)
- Your HIV viral load must be under 50 copies/mL and you must be on a stable HIV medication regimen
- There must be no current serious HIV-related complications
- You cannot have certain past brain cancers or diseases (like primary CNS lymphoma or progressive PML)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving people with HIV a liver from an HIV-positive donor is safe and works well. It looks at infections, cancer risks, and long-term health after transplant.
This study tests whether it's safe and effective for people with HIV to receive a liver transplant from a donor who also has HIV. It aims to expand access to transplants for people with HIV.
This study tests whether kidney transplants from donors with HIV are safe and effective for people with HIV who need a new kidney. It looks at long-term outcomes like rejection and survival.
This trial tests whether hearts from donors who had HIV can be safely transplanted into people with HIV who need a heart transplant. It may offer a new option for those on the waiting list.
This trial tests a combination of low-dose radiation, chemotherapy, and donor immune cells to help your body accept a living donor kidney without long-term anti-rejection drugs.
This trial tests whether giving a special type of immune cells from your kidney donor (called ECP-DL cells) can help your body accept the new kidney without strong anti-rejection drugs. It is for people who are getting their first kidney transplant from a donor who is not a perfect genetic match.
Hear when a new End Stage Renal Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.